Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1776111 · MBX

MBX Biosciences, Inc.

Filing with the SEC SEC-reporting company Carmel, IN Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Several leadership changes3 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Net loss in 2025Net loss of $87M for the year (2024: −$61.9M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$87M−$61.9M
Total assets$385M$269M
Total liabilities$15.9M$11.1M
Stockholders’ equity$369M$257M
Cash and equivalents$75.3M$49.4M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
MBX Biosciences, Inc.
CIK
0001776111
Tickers
MBX
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Carmel, Indiana
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 22, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 9, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 9, 2026 · filing
  • Director or officer change: Director change
    Form 8-K · items 5.02, 9.01 · filed Oct 22, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed Aug 6, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07 · filed Jun 5, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 7, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 7, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 12, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 12, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 9.01 · filed Feb 27, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 22, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed Jan 12, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02 · filed Nov 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Sep 25, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 22, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 7, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 7, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07 · filed Jun 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 7, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 17, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 17, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed Jan 7, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Sep 23, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Sep 23, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Sep 23, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Sep 23, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Aug 23, 2024 · filing